Navigation Links
Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
Date:12/11/2008

h treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and/or exenatide once weekly and the revenues generated from BYETTA may be affected by competition; unexpected new data; safety and technical issues; clinical trials, including the clinical trials mentioned in this press release, not being completed in a timely manner, not confirming previous results, or not achieving the intended clinical endpoints; the DURATION-1 study extension results potentially not being accepted to support comparability; pre-clinica
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
2. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
3. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
4. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
5. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
6. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
7. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
8. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
9. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
10. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- LCA-Vision Inc. (NASDAQ: LCAV ), a leading provider ... brand, announces that all nominees to the company,s Board of ... of stockholders.  These Directors are: , William ... Gaynor Investment Counsel , John C. Hassan ... Edgar F. Heizer III , Chairman of Manus Health ...
(Date:5/21/2013)... 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated ... greatest number of "Emerging" small molecule biotech company ... Alexay .  "No one saw this coming", ... show,s still 4 months away and we may end ... big surprise and great news for attendees". Thecurrent list ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... enjoyed widespread use of its flocked swabs line, branded ... of bacterial and viral samples. FLOQSwabs ... to collect more sample and elute the entire sample ... agents. In spite of this success, the company has ...
... Dec. 16, 2010 Astrum Hearing Inc., an organization of ... way affiliated with Astrum Marketing Inc., also known as Astrum ... bankruptcy pending in the Middle District of Florida. In addition, ... "Sears Hearing By Astrum" centers. Astrum Hearing Inc. ...
Cached Medicine Technology:COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs 2Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing 2
(Date:5/21/2013)... May 21, 2013 Today, Zane Benefits, ... and FSA accounts. Zane Benefits, which provides comprehensive ... is the leader in defined contribution and ... . , According to Zane Benefits’ website, the Affordable ... signed into law in 2010 and impacts many areas ...
(Date:5/21/2013)... While North Carolina is synonymous with golf, ... Brunswick Plantation & Golf Resort is synonymous with affordable ... 27 holes of "Top10" championship golf. , With ... the Top 10 from an industry expert ... task of selecting the course to play. Guests staying ...
(Date:5/21/2013)... By Steven Reinberg HealthDay Reporter , , TUESDAY, ... it comes to steroid therapy for patients having severe ... Swiss investigators. Five days of glucocorticoid treatment with ... the standard 14 days, but with fewer chances for ... show that a shorter period of treatment was not ...
(Date:5/21/2013)... ─ A study of veterans at high risk for ... can be highly effective in helping clinicians spot tiny ... may indicate the earliest stages of the disease. LDCT ... a conventional CT scan. , Results of the study ... , "Lung cancer is the leading cause of cancer-related ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... may be at increased risk of suffering depression after ... researchers hope they can use the findings to develop ... who are vulnerable to postpartum depression, which affects around ... in the May 21 issue of the journal ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3
... first case of bird flu has been reported in Turkey. ... reported from farm in Balikesir province near the Aegean Sea ... farm animals and birds are being slaughtered in order to ... humans. Though, wildlife and health experts maintain that indiscriminate culling ...
... life of dignity with access to medicines and care that ... say experts on the eve of World Hospice and Palliative ... like Kerala, Maharashtra, Karnataka and Orissa as well as the ... strong pain killers that make life more bearable., ,But ...
... regulatory mechanisms that control coordinate gene expression is ... orthologous DNA sequences from multiple vertebrate or invertebrate ... elements central to the dynamic interplay between a ... termed phylogenetic footprinting, is based on the hypothesis ...
... are found to have a higher risk of developing breast ... the same, a new research has concluded. //, ,Hodgkin's ... other immune system organs. Researchers found that women had a ... survived Hodgkin's lymphoma. Dr Lois B. Travis, from the National ...
... can be materialized by increasing cigarette taxes, raising the smoking ... or delay youth smoking according to a researchers. // ... billions of people addicted to this habit. It is time ... , “Our research shows that reducing smoking initiation in youth ...
... at the Indraprastha Apollo Hospital in New Delhi expressed hope ... be successfully separated. // , ,The twins who are ... Hospital and doctors say that a major impediment to the ... blood drainage vessel in the brain. Another possible roadblock is ...
Cached Medicine News:Health News:Terminally Ill deserves a better quality of Life 2Health News:Terminally Ill deserves a better quality of Life 3Health News:Evoprinter, a multigenomic comparative tool for rapid identification of functionally important DNA 2Health News:Lawmakers alerted on new tobacco control policies by research team 2
For the quantitative in vitro determination of Valproic Acid in human serum...
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: